Medical Alert for Patients with Epilepsy: FDA MedWatch Nationwide Recall on Lamotrigine Tablets, 100 mg, 100 Count Bottles, Lot #331771 by Taro Pharmaceuticals

At the Epilepsy Foundation Central & South Texas, our mission is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives. On January 10, 2020, the U.S. Food & Drug Administration (FDA) announced a recall on Lamotrigine Tablets USP 100 mg by Taro Pharmaceuticals. The recalled tablets may contain small...

Read More